Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Trujillo

Concepts (168)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
16
2026
124
6.670
Why?
Students, Pharmacy
14
2026
96
4.090
Why?
Hypoglycemic Agents
21
2025
1411
3.420
Why?
Diabetes Mellitus, Type 2
22
2025
2623
3.150
Why?
Educational Measurement
11
2026
329
2.660
Why?
Glucagon-Like Peptides
5
2020
76
1.640
Why?
Curriculum
11
2026
1074
1.460
Why?
Glucagon-Like Peptide 1
6
2018
150
1.450
Why?
Peptides
7
2018
991
1.330
Why?
Artificial Intelligence
2
2026
385
1.300
Why?
Receptors, Glucagon
3
2015
27
1.270
Why?
Insulin Glargine
4
2022
88
1.190
Why?
Hypoglycemia
6
2022
489
1.050
Why?
Insulin
8
2022
2524
0.870
Why?
Education, Distance
1
2025
59
0.850
Why?
Writing
1
2026
101
0.850
Why?
Pharmacists
4
2026
260
0.830
Why?
Blood Glucose
9
2020
2357
0.730
Why?
Osteoarthritis
1
2025
204
0.720
Why?
Teaching
2
2015
243
0.700
Why?
Liraglutide
4
2016
32
0.690
Why?
Schools, Pharmacy
4
2026
48
0.680
Why?
Immunoglobulin Fc Fragments
3
2020
41
0.680
Why?
Glucagon-Like Peptide-2 Receptor
5
2018
16
0.640
Why?
Anti-Obesity Agents
3
2016
67
0.640
Why?
Glucagon-Like Peptide-1 Receptor
5
2020
88
0.610
Why?
Glucagon
1
2020
114
0.570
Why?
Metformin
2
2020
328
0.570
Why?
Recombinant Fusion Proteins
3
2020
662
0.570
Why?
Emergency Treatment
1
2020
122
0.560
Why?
Medication Therapy Management
1
2019
73
0.540
Why?
Weight Loss
7
2025
857
0.530
Why?
Societies, Pharmaceutical
2
2016
14
0.520
Why?
Hyperglycemia
2
2014
381
0.520
Why?
Patient Education as Topic
4
2018
769
0.510
Why?
Humans
44
2026
145625
0.480
Why?
Gastrointestinal Diseases
1
2018
220
0.470
Why?
Education, Pharmacy, Graduate
2
2017
13
0.420
Why?
Drugs, Investigational
1
2014
31
0.420
Why?
Problem-Based Learning
2
2017
97
0.410
Why?
Drug Combinations
4
2018
399
0.390
Why?
Body Weight
4
2020
964
0.380
Why?
Health Literacy
1
2015
182
0.370
Why?
Peer Review
1
2012
47
0.350
Why?
Drug Administration Schedule
3
2020
782
0.350
Why?
Clinical Trials, Phase III as Topic
3
2022
116
0.350
Why?
Patient-Centered Care
1
2016
551
0.340
Why?
Interpersonal Relations
1
2014
387
0.320
Why?
Learning
1
2015
446
0.320
Why?
Diet Records
1
2009
87
0.290
Why?
Pancreatitis
1
2010
146
0.280
Why?
Faculty, Medical
1
2012
305
0.280
Why?
Cultural Competency
1
2009
83
0.280
Why?
Drug Interactions
1
2009
403
0.270
Why?
Cardiovascular Diseases
2
2017
2218
0.260
Why?
Communication
4
2016
979
0.250
Why?
Attitude of Health Personnel
3
2015
1212
0.240
Why?
Empathy
1
2009
184
0.240
Why?
Peer Group
1
2008
250
0.240
Why?
Diabetes Mellitus
2
2020
1101
0.240
Why?
Program Evaluation
3
2017
945
0.240
Why?
Clinical Protocols
1
2008
279
0.230
Why?
Clinical Trials as Topic
3
2020
1062
0.230
Why?
School Admission Criteria
1
2026
35
0.230
Why?
Accreditation
1
2026
100
0.230
Why?
Competency-Based Education
1
2026
82
0.220
Why?
Obesity
2
2016
3123
0.220
Why?
Drug Therapy, Combination
2
2020
1034
0.220
Why?
Faculty, Pharmacy
1
2024
20
0.210
Why?
Drug Utilization Review
1
2004
60
0.200
Why?
Spironolactone
1
2004
40
0.200
Why?
Family Practice
1
2008
422
0.200
Why?
Venoms
2
2015
22
0.200
Why?
Mineralocorticoid Receptor Antagonists
1
2004
69
0.190
Why?
Gastric Inhibitory Polypeptide
1
2022
13
0.190
Why?
Reproducibility of Results
2
2026
3396
0.170
Why?
Injections, Subcutaneous
2
2014
170
0.170
Why?
Internet
1
2025
656
0.160
Why?
Administration, Intranasal
1
2020
94
0.150
Why?
Patient Compliance
1
2004
587
0.150
Why?
Professional Role
2
2019
171
0.150
Why?
Delayed-Action Preparations
1
2020
191
0.150
Why?
Nausea
1
2020
111
0.150
Why?
Cardiovascular System
1
2020
137
0.140
Why?
Postprandial Period
1
2018
114
0.130
Why?
Insulin, Long-Acting
1
2017
65
0.130
Why?
Commission on Professional and Hospital Activities
1
2017
4
0.130
Why?
Canagliflozin
1
2017
11
0.130
Why?
Administration, Oral
1
2020
867
0.130
Why?
Health Knowledge, Attitudes, Practice
2
2016
1403
0.120
Why?
Internship and Residency
1
2008
1269
0.120
Why?
Perception
1
2019
372
0.120
Why?
Glucosides
1
2017
56
0.120
Why?
Professional Practice
1
2016
58
0.120
Why?
Treatment Outcome
3
2020
11744
0.120
Why?
Benzhydryl Compounds
1
2017
81
0.120
Why?
Surveys and Questionnaires
3
2019
6050
0.110
Why?
Drug Approval
1
2015
93
0.110
Why?
Self Care
1
2018
396
0.110
Why?
Sitagliptin Phosphate
1
2015
31
0.110
Why?
Self-Management
1
2018
207
0.110
Why?
Counseling
1
2018
403
0.110
Why?
United States Food and Drug Administration
1
2015
207
0.110
Why?
Randomized Controlled Trials as Topic
2
2015
1754
0.100
Why?
Pyrazines
1
2015
94
0.100
Why?
Thiazolidinediones
1
2015
142
0.100
Why?
Disease Management
1
2018
649
0.100
Why?
Triazoles
1
2015
190
0.100
Why?
United States
4
2026
16041
0.090
Why?
Pilot Projects
2
2008
1878
0.090
Why?
Comprehension
1
2014
175
0.090
Why?
Community Pharmacy Services
1
2012
46
0.090
Why?
Educational Status
1
2014
466
0.090
Why?
Adult
6
2022
40821
0.090
Why?
Retrospective Studies
4
2022
17291
0.080
Why?
Pharmacy Service, Hospital
1
2012
90
0.080
Why?
Incidence
1
2018
2910
0.080
Why?
Feedback
1
2012
180
0.080
Why?
Algorithms
1
2019
1843
0.080
Why?
Comorbidity
1
2015
1652
0.080
Why?
Heart Failure
1
2004
2323
0.080
Why?
Health Care Costs
3
2022
418
0.080
Why?
Continuity of Patient Care
1
2012
297
0.080
Why?
Male
7
2022
73014
0.080
Why?
Data Collection
1
2012
647
0.070
Why?
Female
7
2022
79080
0.070
Why?
Patient Safety
1
2012
351
0.070
Why?
Clinical Competence
1
2016
1261
0.070
Why?
Professional-Patient Relations
1
2009
146
0.070
Why?
Observer Variation
1
2008
355
0.070
Why?
Boston
1
2008
90
0.070
Why?
Advisory Committees
1
2008
228
0.060
Why?
Acute Disease
1
2010
1033
0.060
Why?
Quality Assurance, Health Care
1
2008
339
0.060
Why?
Concurrent Review
1
2004
2
0.050
Why?
Hospitals, Teaching
1
2004
119
0.050
Why?
Massachusetts
1
2004
178
0.050
Why?
Hospitals, Urban
1
2004
140
0.050
Why?
Guideline Adherence
1
2008
585
0.050
Why?
Animals
1
2025
38030
0.040
Why?
Aged
4
2022
26251
0.040
Why?
Patient Care Team
1
2008
700
0.040
Why?
Diabetes Mellitus, Type 1
1
2014
3930
0.030
Why?
Hospitalization
1
2008
2468
0.030
Why?
Analysis of Variance
1
2019
1293
0.030
Why?
Aged, 80 and over
2
2012
8351
0.030
Why?
Middle Aged
3
2012
36359
0.030
Why?
Phentermine
1
2016
14
0.030
Why?
Benzazepines
1
2016
35
0.030
Why?
Severity of Illness Index
1
2004
2910
0.030
Why?
Bupropion
1
2016
47
0.030
Why?
Fructose
1
2016
132
0.030
Why?
Prospective Studies
1
2008
8087
0.030
Why?
Motivation
1
2019
601
0.030
Why?
Naltrexone
1
2016
114
0.030
Why?
Cough
1
2014
123
0.020
Why?
Forced Expiratory Volume
1
2014
451
0.020
Why?
Administration, Inhalation
1
2014
567
0.020
Why?
Pharmacology, Clinical
1
2012
9
0.020
Why?
Medication Reconciliation
1
2012
31
0.020
Why?
Medical Informatics
1
2012
101
0.020
Why?
Health Personnel
1
2017
750
0.020
Why?
Creatinine
1
2012
511
0.020
Why?
Drug Monitoring
1
2012
399
0.020
Why?
Colorado
1
2017
4588
0.020
Why?
Interprofessional Relations
1
2006
274
0.010
Why?
Quality Improvement
1
2012
1325
0.010
Why?
Cohort Studies
1
2012
6045
0.010
Why?
Trujillo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)